These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35291495)

  • 21. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.
    Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y
    World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.
    Yu Y; Gao Y; Yu Y
    Ann Clin Lab Sci; 2021 Nov; 51(6):783-789. PubMed ID: 34921031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
    Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
    Du DX; Lian DB; Amin BH; Yan W
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
    Zhao EH; Shen ZY; Liu H; Jin X; Cao H
    World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
    Wang ZG; Yang YG; Fu GS; Lu DH; Tian SY; Wei W
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5353-5359. PubMed ID: 32495869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WISP1 indicates poor prognosis and regulates cell proliferation and apoptosis in gastric cancer via targeting AKT/mTOR signaling pathway.
    Zhu Y; Li W; Yang Y; Li Y; Zhao Y
    Am J Transl Res; 2020; 12(11):7297-7311. PubMed ID: 33312368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. circRNA RNF111 regulates the growth, migration and invasion of gastric cancer cells by binding to miR‑27b‑3p.
    Wang Z; Jiang Z; Zhou J; Liu Z
    Int J Mol Med; 2020 Nov; 46(5):1873-1885. PubMed ID: 33000178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
    Liu H; Zhao YR; Chen B; Ge Z; Huang JS
    Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
    Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
    Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-200c inhibits proliferation and promotes apoptosis of Wilms tumor cells by regulating akt signaling pathway.
    Zhao GZ; Niu YQ; Li ZM; Kou D; Zhang L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6623-6631. PubMed ID: 32633351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
    Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LINC00355 inhibits apoptosis and promotes proliferation of gastric cancer cells by regulating Wnt/β-catenin signaling pathway.
    Luan PB; Sun XM; Yao J
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8377-8383. PubMed ID: 32894544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells.
    Zhang J; Guo H; Zhu JS; Yang YC; Chen WX; Chen NW
    Oncol Lett; 2014 May; 7(5):1401-1408. PubMed ID: 24765145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SSRP1 promotes colorectal cancer progression and is negatively regulated by miR-28-5p.
    Wu W; He K; Guo Q; Chen J; Zhang M; Huang K; Yang D; Wu L; Deng Y; Luo X; Yu H; Ding Q; Xiang G
    J Cell Mol Med; 2019 May; 23(5):3118-3129. PubMed ID: 30762286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
    Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.